Reference
Nawrocki ST, olea J, Villa CC, Dadrastoussi H, Wu K, Tsao-Wei D, Colombo A, Coffey M, Fernandez HE, Chen X, et al. 2023. Comprehensive single-cell immune profiling defines the patient multiple myeloma microenvironment following oncolytic virus therapy in a Phase 1b trial. Clinical Cancer Research. 29:5087–5103.